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Abstract
Acute ethanol administration increases potent GABAergic neuroactive steroids, specifically (3α,
5α)-3-hydroxypregnan-20-one (3α,5α-THP) and (3α,5α)-3,21-dihydroxypregnan-20-one. In
addition, neuroactive steroids contribute to ethanol actions. Chronic ethanol exposure results in
tolerance to many effects of ethanol, including ethanol-induced increases in neuroactive steroid
levels. To determine the mechanisms of tolerance to ethanol-induced increases in neuroactive
steroids, we investigated critical signaling molecules that are required for acute ethanol effects.
Male Sprague-Dawley rats were administered ethanol via liquid diet for 2 weeks and steroid
levels, adrenocorticotrophic hormone (ACTH) and adrenal steroidogenic acute regulatory (StAR)
protein expression were measured. Chronic ethanol exposure elicits tolerance to ethanol-induced
elevation of serum ACTH and the steroids pregnenolone and progesterone. Surprisingly, chronic
ethanol exposure does not result in tolerance to ethanol-induced increases in adrenal StAR protein.
However, ethanol-induced StAR phosphorylation is decreased when compared to acute ethanol
administration. A separate group of rats exposed to chronic ethanol diet were subsequently
challenged with ethanol (2 g/kg) and exhibited a blunted elevation of serum ACTH and
progesterone as well as cerebral cortical and hippocampal 3α,5α-THP. Administration of ACTH
with the ethanol challenge restored the elevation of serum ACTH and progesterone as well as
cerebral cortical 3α,5α-THP levels to those observed in ethanol-naïve rats. Thus, chronic ethanol
exposure disrupts ACTH release, which results in tolerance to ethanol-induced increases in
neuroactive steroid levels. Loss of the ethanol-induced increases in neuroactive steroids may
contribute to behavioral tolerance to ethanol and influence the progression towards alcoholism.
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Neuroactive steroids produce their effects on membrane receptors that regulate central
nervous system activity rather than on nuclear receptors that regulate gene expression. Thus,
these steroids are capable of eliciting rapid changes in neuronal excitability, primarily
through their enhancement of GABAA receptor activity (for review, see Belelli and Lambert
2005). Neuroactive steroids can be synthesized de novo in the brain or produced
peripherally in the adrenals and gonads. Potent GABAergic neuroactive steroids (3α,5α)-3-
hydroxypregnan-20-one (3α,5α-THP) and (3α,5α)-3,21-dihydroxypregnan-20-one positively
modulate GABAA receptor activity (Majewska et al. 1986) and can elicit many of the same
behavioral effects as ethanol (see Morrow 2007, for review).
Systemic ethanol administration increases serum and brain levels of neuroactive steroids that
contribute to several of the behavioral effects of ethanol. In fact, administration of steroid
biosynthetic enzyme inhibitors or adrenalectomy inhibits or completely blocks specific
ethanol actions. Indeed, GABAergic neuroactive steroids contribute to ethanol's inhibitory
actions on medial septal neurons (VanDoren et al. 2000), as well as antidepressant-like
actions (Hirani et al. 2002), anxiolytic (Hirani et al. 2005), anticonvulsant (VanDoren et al.
2000), hypnotic effects (Khisti et al. 2003b) and spatial learning deficits (Matthews et al.
2002). Furthermore, the GABA agonist-like steroids substitute for ethanol in discrimination
studies in rodents and monkeys (Grant et al. 1996) and their exogenous administration can
alter ethanol drinking patterns (Janak et al. 1998; Finn et al. 1997; Ford et al. 2007; Morrow
et al. 2003). Thus, determining how GABAergic neuroactive steroids are synthesized and
regulated following ethanol administration is important for understanding various ethanol
actions.
It has long been known that adrenocorticotrophic hormone (ACTH) release is important for
adrenal stimulation (Rivier et al. 1984), and acute ethanol administration activates the
hypothalamic-pituitary-adrenal (HPA) axis to increase the stress hormone corticosterone in
rodents (for review, see Rivier 1996). We have recently shown that ethanol-induced
increases in neuroactive steroids in both serum and brain following acute ethanol
administration are dependent upon pituitary ACTH release, de novo adrenal steroidogenic
acute regulatory (StAR) protein synthesis and cytochrome P450 side chain cleavage enzyme
activity (Boyd et al. 2010). Indeed, disruptions or alterations in HPA axis signaling
markedly affect neuroactive steroid levels, and studies involving adrenalectomized animals
have demonstrated the necessity of the adrenals for ethanol-induced increases in serum and
brain neuroactive steroids (Khisti et al. 2003b; O'Dell et al. 2004).
Although activation of the HPA axis is important for steroidogenesis, the rate-limiting step
is the transfer of cholesterol from the outer mitochondrial membrane to cytochrome P450
side chain cleavage enzyme residing on the inner mitochondrial membrane (Miller 1988).
Cholesterol cannot pass freely across the mitochondrial membranes and must be assisted by
protein transport via StAR in the adrenals. Acute ethanol administration has been shown to
increase adrenal StAR protein concomitantly with serum steroid levels (Khisti et al. 2003a),
and we recently demonstrated that de novo adrenal StAR synthesis is essential for ethanol-
induced increases in serum and brain neuroactive steroids (Boyd et al. 2010). In addition, a
knockout of the StAR gene is lethal in mice (Caron et al. 1997), and mutations in humans
disrupt steroid production causing congenital lipoid adrenal hyperplasia (Lin et al. 1995),
further demonstrating its importance.
Chronic ethanol exposure results in a number of adaptive changes in central nervous system
activity leading to tolerance to the behavioral effects of ethanol (Khanna et al. 1991; Kalant
1998). While chronic ethanol exposure does not affect basal levels of neuroactive steroids,
tolerance develops to ethanol-induced increases in steroid levels (Janis et al. 1998), and the
effect of subsequent ethanol challenge on cortical 3α,5α-THP levels is blunted (Morrow et
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al. 2001). In addition, adrenalectomized rodents have reduced levels of neuroactive steroids,
exhibit tolerance to the sedative-hypnotic effects of ethanol (Khisti et al. 2003b) and display
increased ethanol withdrawal severity (Gililland and Finn 2007).
Because behavioral effects of ethanol are partially dependent on ethanol-induced
steroidogenesis, the loss of this effect following chronic ethanol exposure may contribute to
ethanol tolerance. Focusing on the mechanisms of steroido-genesis recently found to be
critical for increases in neuroactive steroids following acute ethanol administration, the
present study investigated the mechanisms that underlie tolerance to ethanol-induced
increases in neuroactive steroids resulting from chronic ethanol exposure. Tolerance to
ethanol-induced increases in neuroactive steroids may alter ethanol sensitivity and
contribute to risk for alcoholism and alcohol use disorders.
Materials and methods
Animals
Male Sprague-Dawley rats weighing between 225 g and 350 g were used for all experiments
(Harlan, Indianapolis, IN, USA). The animals were group housed (three per cage) and
maintained in 12-h light and dark (lights on, 7:00 AM to 7:00 PM) conditions with food and
water available ad libitum. Rats were acclimated to handling for 1 week before the test day.
All experiments were conducted in accordance with the guidelines of the National Institutes
of Health Guide for the Care and Use of Laboratory Animals and approved by the
Institutional Animal Care and Use Committee of the University of North Carolina at Chapel
Hill.
Chronic ethanol liquid diet administration
Rats were housed individually and administered a nutritionally complete liquid diet for the
first 3 days (Custom Stanley Diet, MP Biomedicals, Costa Mesa, CA, USA). Rats then
received ethanol (6% v/v) in liquid diet for 7 days, followed by an increase to 7.5% ethanol
for the duration of the study. Control rats were fed the identical diet with dextrose
substituted isocalorically for ethanol. Water was available ad libitum and dietary
consumption was monitored daily (the rats consumed 8–10 g/kg/day). The mean body
weights for the controls and ethanol diet rats were similar at the termination of the
experiment. This procedure reliably results in physical dependence on ethanol (Morrow et
al. 1992). Ethanol dependent rats had free access to ethanol diet up until the time of killing.
Separate groups of rats that consumed ethanol by liquid diet for 14 days were injected with a
challenge dose of ethanol (2 g/kg, 20% v/v in saline, i.p.) and tissue was collected after 60
min. These rats were denied access to ethanol and fed standard chow for 24 h prior to the
ethanol challenge. Rats receiving exogenous ACTH were administered two doses of ACTH
(2 μg, i.p.), one concurrently with the saline or ethanol challenge and one 30 min later.
Tissue was collected 60 min after the saline or ethanol challenge. All rats were habituated to
saline injections and were killed by decapitation. Blood alcohol levels were measured from
6 μL aliquots of serum using a SRI 8610c gas chromatograph (Torrance, CA, USA) as
previously described (Boyd et al. 2008).
Tissue and protein preparations
Mitochondrial membrane fractions from adrenal glands were prepared by homogenization,
low speed centrifugation in 0.32 M sucrose and centrifugation of the supernatant at 17 000 g
for 30 min. The pellet (mitochondrial fraction) was resuspended in phosphate-buffered
saline. Individual cerebral cortices, as well as other brain regions, were homogenized
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directly in 2% sodium dodecyl sulfate (SDS). Protein measurement was conducted using a
BCA protein assay (Thermo Fisher Scientific Inc, Rockford, IL, USA).
Western blot analysis
Adrenal mitochondrial fractions and cerebral cortical homogenate were subjected to SDS–
polyacrylamide gel electrophoresis (SDS–PAGE) using Novex Tris–Glycine gels (8–16%),
transferred to polyvinylidene diflouride membranes (Invitrogen, Carlsbad, CA, USA) and
probed with StAR antibody (1 : 1000) (Abcam, Cambridge, MA, USA). Blots were
subsequently exposed to a second primary antibody directed against β-actin (1 : 1000)
(Millipore, Bilerica, MA, USA) to verify equivalent protein loading and transfer. Bands
were detected by enhanced chemiluminescence (GE Healthcare, Piscataway, NJ, USA),
apposed to x-ray films under non-saturating conditions and analyzed by densitometric
measurements using NIH Image 1.57. All comparisons were made within blots and
statistical analysis was conducted using Student's t-test or one-way ANOVA.
Phospho-protein kinase A substrate immunoprecipitation analysis
Protein in the mitochondrial fraction was immunoprecipitated with phospho-protein kinase
A (PKA) substrate antibody (Cell Signaling Technology Inc., Danvers, MA, USA) as
previously described (Kumar et al. 2002). Briefly, mitochondrial protein (200 μg) was
solubilized and denatured in radioimmunoprecipitation assay buffer (Sigma-Aldrich, St.
Louis, MO, USA) with phosphatase inhibitor cocktail (Sigma-Aldrich),
phenylmethylsulfonyl fluoride (1 mM), sodium fluoride (50 mM), sodium vanadate (200
μM) and EDTA (2 mM) to prevent protein degradation and dephosphorylation. This fraction
was centrifuged at 10 000 g and supernatant (solubilized protein) was collected.
Denaturation of protein in the supernatant was confirmed by SDS–PAGE analysis.
Immunoprecipitation of phosphoproteins for detection of phospho-StAR was performed
using antibody conjugated to Dynal beads (Invitrogen) and western blot analysis of the
immunoprecipitate. The optimal antibody and protein concentrations for
immunoprecipitation were determined in pilot experiments to optimize the conditions. The
phospho-PKA substrate specific antibody (Rockland Inc., Gilbertsville, PA, USA) was
linked to Dynal beads by incubating 125 μL of Dynal beads with 100 μL of antibody (0.35
μg/μL) for 1 h at 22–24°C. The solubilized receptors were mixed with antibody-linked beads
in a final volume of 500 μL and incubated on an orbital shaker overnight at 4°C. The
receptor-antibody-bead complex was washed three times with phosphate-buffered saline,
resuspended in 50 μL of SDS and boiled for 5 min. Phosphoprotein immunoprecipitates and
adrenal mitochondrial fractions were subsequently analyzed by SDS–PAGE gel
electrophoresis and western blotting to examine the effects of ethanol exposure on phospho-
StAR protein and total StAR protein.
Radioimmunoassay of neuroactive steroid 3α,5α-THP
Radioimmunoassays (RIAs) were conducted as previously described (Janis et al. 1998).
Briefly, brain samples were weighed and suspended in 2.5 mL of 0.3 N NaOH,
homogenized with a sonic dismembrator and extracted three times with 3 mL aliquots of
10% ethyl acetate in heptane (v/v). Extraction recovery was monitored by the addition of
2000 cpm of [3H]3α,5α-THP (PerkinElmer, Waltham, MA, USA). The brain extracts were
purified using solid phase silica columns (Burdick and Jackson, Muskegon, MI, USA) and
subsequently dried. Samples were reconstituted and assayed in duplicate by the addition of
[3H]3α,5α-THP and polyclonal sheep anti-3α,5α-THP antibody (Obtained from Dr. Robert
Purdy, Scripps Research Institute). Total binding was determined in the absence of
unlabeled 3α,5α-THP and non-specific binding was determined in the absence of antibody.
The antibody binding reaction was allowed to equilibrate for 2 h and cold dextran coated
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charcoal was used to separate bound from unbound steroid. Bound radioactivity was
determined by liquid scintillation spectroscopy. Steroid levels in the samples were
extrapolated from a concurrently run standard curve and corrected for their respective
extraction efficiencies. The inter-assay coefficient of variation was 9.1% and the intra-assay
coefficient of variation is 2.2%. The 3α,5α-THP antibody has minimal cross-reactivity with
other circulating steroids (Janis et al. 1998). 3α,5α-THP antiserum cross-reacts with
progesterone < 3%, 3α,5β-THP 6.6%, 3β,5α-THP 2.8%, 3β,5β-THP 0.5%, 5α-pregnan-3α,
20α-diol 0.1% and 5α-pregnan-3,20-dione 3.5%. The antiserum cross-reacts with (3α)-3-
hydroxy-4-pregnen-20-one > 100%. This steroid is also a potent modulator of GABAA
receptors (Morrow et al. 1990) and has been found at comparable levels to 3α,5α-THP in
serum (Wiebe et al. 1994), but at markedly lower levels than 3α,5α-THP in cerebral cortex
(Griffin and Mellon 2001).
RIA of steroid precursor pregnenolone
Pregnenolone levels were measured by RIA, as previously described (Porcu et al. 2006).
Briefly, pregnenolone was extracted from 250 μL of serum with 2 mL of diethyl ether three
times. Extraction recovery was monitored by the addition of 1000 cpm of [3H]pregnenolone
(MP Biomedicals). Samples were reconstituted and assayed in duplicate by the addition of
[3H]pregnenolone and anti-pregnenolone antibody (MP Biomedicals). Total binding was
determined in the absence of unlabeled pregnenolone and non-specific binding was
determined in the absence of antibody. The antibody binding reaction was allowed to
equilibrate for a minimum of 4 h and cold dextran coated charcoal was used to separate
bound from unbound steroid. Bound radioactivity was determined by liquid scintillation
spectroscopy. Steroid levels in the samples were extrapolated from a concurrently run
standard curve and corrected for their respective extraction efficiencies. The antiserum
cross-reacts with 3α,5α-THP 16%, 3α,5β-THP 5.9%, progesterone 3.1%, (3α,5α)-3,21-
dihydroxypregnan-20-one 1.1%. All of the following steroids had less than 1% cross-
reactivity: 5α-dihydroprogesterone, 17α-hydroxyprogesterone, deoxycorticosterone, cortisol,
11-deoxycortisol, corticosterone, androsterone, 5α-dihydrotestosterone, cholesterol, 17β-
estradiol, estrone and estriol. The intra-assay and inter-assay coefficients of variation were
7.71% and 5.93%, respectively.
RIA of progesterone and ACTH
Serum progesterone and ACTH levels were measured using RIA kits according to the
manufacturer's instructions (MP Biomedicals). Trunk blood was collected and spun down at
1730 g for 15 min at 4°C to obtain serum, and ACTH and progesterone levels were
measured on the day of tissue collection. Total binding was determined in the absence of
unlabeled progesterone or ACTH, and non-specific binding was determined in the absence
of antibody. Steroid levels in the samples were extrapolated from a concurrently run
standard curve. The intra-assay and inter-assay coefficients of variation for progesterone are
3.6% and 6.7% and for ACTH are 4.1% and 3.9%, respectively.
Data analysis
Results are expressed as mean ± SEM. Steroid levels are expressed as ng/g for brain tissue
and ng/mL for serum. Western blot data were normalized to β-actin signals from the same
blot and expressed as % control values taken from each blot. Significance was determined
by ANOVA followed by post-hoc tests or the Student's t-test as appropriate. Analyses were
performed using the software GraphPad Prism version 4 (GraphPad Software, San Diego,
CA, USA).
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Neuroactive steroids are not increased after chronic ethanol exposure
To determine if chronic ethanol exposure for 2 weeks elicits changes in steroid biosynthesis
we first measured levels of the neuroactive steroid precursors. Rats were chronically
exposed to ethanol through a nutritionally complete liquid diet and serum steroid levels were
measured. Following chronic ethanol administration, there were no changes in serum
ACTH, pregnenolone or progesterone (Fig. 1a–c) compared to pair-fed control rats. Our lab
has previously shown that there are also no increases in serum or cerebral cortical 3α,5α-
THP in dependent rats (Janis et al. 1998).
Chronic ethanol exposure blunts the neuroactive steroid response to an ethanol challenge
Next, we investigated the steroid response to an ethanol challenge (2 g/kg, i.p.) in rats
chronically exposed to ethanol for 2 weeks and withdrawn for 24 h. We challenged the rats
with 2 g/kg ethanol because previous studies demonstrated that 2 g/kg produced a maximal
effect on neuroactive steroid levels (VanDoren et al. 2000; Boyd et al. 2010). In the group
of rats administered control diet, ethanol challenge resulted in increased serum ACTH levels
compared to rats administered a saline challenge. However, rats exposed to chronic ethanol
in their diet exhibited reduced serum ACTH levels compared to the control diet group
challenged with ethanol, and no change in serum ACTH levels compared to rats fed control
diet and challenged with saline [F(3,31) = 6.92, p = 0.0011; Fig. 2a]. Furthermore, the
ethanol challenge of rats exposed to chronic ethanol did not significantly alter serum ACTH
compared to chronic ethanol exposed rats administered a saline challenge. These rats also
showed similar results for serum progesterone levels [F(3,15) = 27.28, p < 0.0001; Fig. 2b],
as well as cerebral cortical 3α,5α-THP levels [F(3,14) = 14.2, p = 0.0002; Fig. 2c]. Indeed,
ethanol administration to rats administered control diet increased steroid levels in serum and
brain that were lost following chronic ethanol exposure. Ethanol challenge resulted in a
blunted steroid response in both serum and brain that was not significantly different from the
effect of saline challenge in the chronic ethanol-exposed group. Importantly, there does not
appear to be any effect of the control diet on ACTH or steroid levels, and rats in the control
diet group respond to the 2 g/kg ethanol challenge similarly to a naïve animal (Boyd et al.
2010). Finally, ethanol challenge produced similar blood alcohol concentrations in rats
administered ethanol diet for 2 weeks (223 ± 6 mg/dL, n = 21) versus ethanol naïve rats
tested in our previous studies (237 ± 8 mg/dL, Khisti et al. 2003a); 166 ± 12 mg/dL (Boyd et
al. 2008); 257 ± 6 mg/dL (Porcu et al. 2010), suggesting that metabolic tolerance did not
contribute to the effects of chronic ethanol liquid diet exposure on neuroactive steroid levels.
The importance of StAR protein phosphorylation for neuroactive steroid synthesis
Because chronic ethanol exposed rats appeared to be tolerant to ethanol-induced increases in
serum pregnenolone and progesterone, this suggested that adaptations must have occurred in
adrenal steroid biosynthetic mechanisms. Thus, we investigated the effects of chronic
ethanol exposure on the cholesterol transport protein StAR. Chronic ethanol administration
increases adrenal StAR protein 3.26-fold compared to control diet [t(22) = 4.95, p < 0.0001;
Fig. 3a]. This increase in adrenal StAR protein expression is similar to that observed
following acute ethanol administration (Fig. 4). However, the 2 g/kg ethanol challenge does
not have any further effect on adrenal StAR protein compared to chronic ethanol-exposure
and the saline challenge (Fig. 3b). Furthermore, while acute ethanol administration increases
StAR phosphorylation [t(6) = 3.75, p = 0.0096], chronic ethanol administration does not
alter StAR phosphorylation compared to rats administered control diet, suggesting the
development of tolerance to ethanol enhanced StAR phosphorylation (Fig. 4).
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Restoration of ACTH levels restores neuroactive steroid levels following chronic ethanol
exposure
Because rats chronically exposed to ethanol appeared to be tolerant to increases in both
ACTH and neuroactive steroid levels following an ethanol challenge, we examined if
exogenous ACTH replacement could restore ethanol-induced steroidogenesis. Separate
groups of rats were administered liquid diet as described above; however, in this experiment,
all groups received ethanol diet, and we examined the effect of ACTH replacement with the
saline or ethanol challenge. The ethanol challenge, in combination with exogenous ACTH
administration, increased serum ACTH and progesterone, as well as cerebral cortical 3α,5α-
THP levels (Fig. 5a–c). Remarkably, ACTH restored the effect of ethanol on steroid levels
to similar concentrations found in naïve animals administered ethanol (Boyd et al. 2010).
Chronic ethanol exposed rats administered saline and ACTH have elevated ACTH levels
compared to ethanol exposed rats administered saline without ACTH. Moreover, chronic
ethanol exposed rats challenged with ethanol and ACTH show increased serum ACTH
compared to chronic ethanol exposed rats challenged with ethanol alone, as well as rats
challenged with saline and ACTH [F(3,29) = 10.24, p < 0.0001; Fig. 5a]. These rats also
showed similar results for serum progesterone levels [F(3,30) = 25.35, p < 0.0001; Fig. 5b]
as well as cerebral cortical 3α,5α-THP levels [F(3,30) = 7.39, p = 0.0008; Fig. 5c]. Indeed,
serum progesterone and cerebral cortical 3α,5α-THP were greater in chronic ethanol
exposed rats challenged with ethanol and ACTH compared to those challenged with ethanol
alone, or those challenged with saline and ACTH.
As ACTH administration following chronic ethanol exposure in rats restored the ethanol-
induced increases in serum and brain steroid levels, we also examined whether it reinstated
the phosphorylation of StAR. Adrenals were used from the same rats as steroid
measurements in Fig. 5 and results are presented as the fold increase of phosphorylated or
total StAR for each group compared to chronic ethanol exposed rats administered a saline
challenge. Chronic ethanol exposed rats receiving the ethanol challenge, saline + ACTH
challenge, or ethanol + ACTH challenge, all exhibited increases in phosphorylated StAR
protein [F(5,28) = 2.9, p = 0.031; Fig. 6]. While post-hoc tests revealed no significant
differences between groups, ethanol + ACTH increased StAR phosphorylation to a much
greater extent than ethanol challenge alone, suggesting a possible trend. By comparison,
total StAR was not elevated in any group, suggesting that the observed increases in
phosphorylated StAR cannot be attributed to an increase in total StAR protein.
Discussion
Changes in GABAA receptor activity contribute to tolerance and dependence following
prolonged exposure to ethanol (for review, see Kumar et al. 2009). The ethanol-induced
increases in neuroactive steroids, which positively modulate GABAA receptor activity, were
lost after chronic ethanol exposure. This loss of neuroactive steroid production may
influence GABAA receptor function and contribute to tolerance to ethanol's effects. Results
of the present study indicated that blunted ACTH levels, as well as the loss of StAR
phosphorylation, following chronic ethanol exposure dramatically altered serum and brain
neuroactive steroid levels. Importantly, exogenous ACTH completely restored the
neuroactive steroid response in serum and brain, which suggested that these are important
mechanisms altered by chronic ethanol exposure.
Hypothalamic-pituitary-adrenal axis activity is important for steroidogenesis and CNS
functions as dysregulation of the HPA axis has been shown to be associated with altered
steroid responses as well as depression and various other mood disorders (McQuade and
Young 2000). When the HPA axis is functioning properly, steroids, including GABAergic
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neuroactive steroids, are increased by HPA axis activation, but also provide negative
feedback to inhibit corticotropin releasing factor (CRF) production and release, ACTH
release and corticosterone levels in rodents (for review, see Morrow et al. 2006). In the
present study, the blunted steroid response observed after chronic ethanol exposure appears
to be related to dysregulation of the HPA axis, as we also observed blunted ACTH levels
following chronic ethanol exposure. Indeed, ACTH stimulation of adrenal function is
essential for steroidogenesis as well as adrenal integrity. In fact, the tolerance to increased
ACTH levels was concomitant with tolerance to increased neuroactive steroid levels
observed following chronic ethanol exposure. These results are congruent with previous data
where hypophysectomized rats displayed atrophied adrenals characterized by reduced
weight and less steroidogenic output (Colby et al. 1974; Boyd et al. 2010), which
demonstrated the importance of ACTH signaling. Furthermore, the fact that tolerance to
ethanol-induced increases in neuroactive steroids occurred in both serum and brain further
exemplified the significance of HPA axis signaling and the adrenal for regulating both
circulating and central levels of neuroactive steroids. It should be pointed out, however, that
RIA may not be sensitive enough to detect localized changes in brain steroidogenesis (Sanna
et al. 2004). Therefore, the effect of chronic ethanol exposure on localized synthesis of
neuroactive steroids is still unknown.
Ethanol-induced elevations of pregnenolone, progesterone and 3α,5α-THP were all blunted
after chronic ethanol exposure, which suggested that alterations occurred early in the
steroidogenic pathway. StAR, which mediates cholesterol transport required for
steroidogenesis, was increased by acute ethanol administration and correlated with increased
steroid levels (Khisti et al. 2003a). Because steroid levels were blunted following chronic
ethanol exposure, we hypothesized that we would also observe changes in StAR protein
expression. Conversely, adrenal StAR protein remained elevated following chronic ethanol
exposure. However, tolerance to ethanol-induced phosphorylation of StAR was observed
after chronic ethanol exposure and may contribute to reduced StAR activity indicated by the
reduced levels of serum pregnenolone.
Alterations in ACTH following chronic ethanol exposure may explain the blunted
neuroactive steroid responses directly, because of adrenal stimulation, and indirectly,
through phosphorylation of StAR. Indeed, ACTH increases cAMP, and previous studies
have demonstrated the importance of PKA phosphorylation for the activity of StAR
(Arakane et al. 1997). Furthermore, experiments in Leydig cells demonstrated that protein
kinase C activation could elicit increases in StAR protein expression, but protein kinase C
did not increase steroid levels or phosphorylate StAR. However, addition of a cAMP
analogue increased StAR phosphorylation and steroid levels (Jo et al. 2005). Thus, increases
in StAR protein expression do not promote steroidogenesis if StAR is not phosphorylated.
In the present study, exogenous ACTH administration to dependent rats restored the ethanol-
induced steroid response, which suggested that ACTH was critical. Although StAR was still
increased following chronic ethanol exposure, steroid levels were blunted without
exogenous ACTH administration. However, chronic ethanol exposed rats challenged with
ethanol still showed increases in phosphorylated StAR despite the blunted ACTH release.
This suggests that ACTH is not the only factor controlling the phosphorylation of StAR and
that ethanol may stimulate StAR phosphorylation via another mechanism. Nevertheless,
when exogenous ACTH was administered with an ethanol challenge, the full steroidogenic
response was restored. Thus, following chronic ethanol exposure, increases in adrenal StAR
protein expression and StAR phosphorylation are not sufficient for maximal steroidogenesis.
Although the present study did not explore effects of chronic ethanol exposure on HPA axis
function upstream of ACTH, these effects likely regulate ACTH release. Indeed, knocking-
Boyd et al. Page 8













out the type 1 CRF receptor in mice blunted the ACTH response to ethanol, and repeated
alcohol exposure blunted CRF and type 1 CRF receptor activity as well as ACTH response
(Lee et al. 2001b,a). However, regardless of where proper functioning is altered, blunted
ACTH release is an important consequence of chronic ethanol exposure. Following repeated
ethanol exposure to rats, the ACTH response to an acute ethanol challenge has been shown
to remain blunted for at least 21 days, which would correspond to over 1 year in humans
(Rivier and Lee 2001). Interestingly, in a subsequent study, the blunting of the ACTH
response to acute ethanol challenge was not permanent (Lee and Rivier 2003). However, if a
short duration of repeated ethanol exposure alters ACTH function for an extended period of
time, then prolonged ethanol dependence might cause more pronounced, or even permanent,
effects. Furthermore, after repeated exposure to a stimulus such as ethanol, the HPA axis
does not respond to the same stimulus, but remains capable of mounting a full response to
different stimuli (Rivier and Lee 2001). This result suggests that the HPA axis is extremely
complex, as ethanol is specific in blunting the axis response to future ethanol exposures
while, at the same time, maintaining full HPA axis activation to new stressors. Perhaps
ethanol is targeting extrahypothalamic mechanisms to initiate HPA axis activity.
Different laboratories employ various paradigms for chronic ethanol administration with
differences in lengths and routes of exposure. Our method of 2 weeks of ethanol in a liquid
diet reliably results in physical dependence on ethanol (Morrow et al. 1992). In addition,
extending the ethanol diet out to 6 weeks produced the same effect in terms of blunted
ACTH and steroid levels (unpublished result). Moreover, when dependent rats were
challenged with a 2 g/kg dose of ethanol they no longer responded like naïve animals, which
suggested ethanol tolerance. ACTH and neuroactive steroid levels were blunted whether we
challenged the animal on the 15th day of liquid diet administration or 24 h following ethanol
withdrawal. Similar alterations in neuroactive steroid levels have been seen in other chronic
models where the loss of neuroactive steroid production was linked to behavioral effects
such as increased anxiety and seizure susceptibility (Cagetti et al. 2004).
Because neuroactive steroids contribute to many of the effects of ethanol, tolerance to
ethanol-induced increases in neuroactive steroids may lead to increased consumption of
alcohol. Indeed, chronic ethanol exposed rats that no longer have elevated 3α,5α-THP levels
readily self-administer ethanol, but this can be reduced by 3α,5α-THP administration
(Morrow et al. 2001). Conversely, 3α,5α-THP appears to be rewarding in non-dependent
rats (Janak et al. 1998), hence tolerance to increased steroid levels may promote greater
drinking to achieve the same pharmacological effects. These ideas remain speculative,
however, and further studies are needed to determine the role of endogenous neuroactive
steroids in ethanol drinking behavior.
Because neuroactive steroids appear to contribute to ethanol sensitivity (Morrow 2007;
Morrow and Porcu 2009), and HPA axis activation contributes to steroidogenesis, it is
reasonable to suggest that proper HPA axis functioning plays a role in ethanol sensitivity. In
fact, clinical studies have shown a link between alcoholism and alterations in HPA axis
functioning (Adinoff et al. 2005; Lovallo et al. 2000). In rats, it has been suggested that the
loss of elevated ACTH and steroid responses following chronic drinking are more important
than low basal hormone levels for the escalation of drinking. In addition, the opioid
antagonist naltrexone, which has been shown to reduce relapse risk in human alcoholics,
activates the HPA axis and increases ACTH and steroid levels (O'Malley et al. 2002).
Furthermore, naltrexone selectively increases serum 3α,5α-THP in heavy drinkers that
harbor the mu opiate receptor polymorphism (Ray et al. 2010), a single nucleotide
polymorphism marker that has been associated with improved treatment response in several
studies (Oslin et al. 2003; Anton et al. 2008). Naltrexone has also been shown to reverse the
suppression of testosterone observed after chronic ethanol exposure (Emanuele et al. 1999).
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Moreover, serum levels of the HPA antagonist leptin are elevated in human alcoholics,
correlated with ethanol consumption (Nicolas et al. 2001), and leptin injections in mice
increase alcohol intake (Kiefer et al. 2001). Furthermore, leptin decreases the expression of
StAR in adrenocortical cells and inhibits steroid synthesis (Cherradi et al. 2001). Together,
all of these results are consistent with the present study and suggest a link between HPA axis
activity, StAR protein, neuroactive steroids and ethanol consumption.
We conclude that pituitary ACTH along with adrenal StAR protein activity are critical for
ethanol-induced increases in neuroactive steroids. Chronic ethanol exposure alters the HPA
axis and blunts both ACTH and steroid responses to subsequent ethanol challenges, and
these phenomena contribute to ethanol tolerance and dependence. The findings of the
present study suggest that ACTH depletion may contribute to ethanol tolerance and
dependence as well as promote associated withdrawal symptoms and continued excessive
drinking.
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Chronic ethanol exposure does not elicit changes in ACTH, pregnenolone or progesterone.
Chronic ethanol exposure was via liquid diet for 2 weeks and (a) ACTH, (b) pregnenolone
and (c) progesterone were measured in serum. n = 8–10 in duplicate.
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Chronic ethanol exposure elicits no change in ACTH levels but reduces the ACTH and
steroid responses to ethanol challenge. Groups of rats administered control (CD) or ethanol
(CE) diet for 2 weeks received a challenge injection of saline (+ S) or ethanol (+ E) (2 g/kg,
i.p.), tissue was collected 60 min post-ethanol administration and serum (a) ACTH and (b)
progesterone (Prog), as well as (c) cerebral cortical 3α,5α-THP were measured. *p < 0.001
and **p < 0.05 compared to CD + S, and #p < 0.01 compared to CD + E (ANOVA followed by
Newman–Keuls test), n = 5–13 in duplicate.
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Adrenal StAR protein is elevated following chronic ethanol exposure but is not further
increased by an ethanol challenge. (a) Adrenal StAR protein expression was measured via
western blot analysis in rats exposed to liquid control (CD) and ethanol (CE) diet,
normalized to β-actin and presented as % control diet. (b) Adrenal StAR protein expression
was also measured in separate groups of rats that were exposed to liquid ethanol diet and
subsequently challenged with saline (CE + S) or ethanol (2 g/kg) (CE + E). Results are
normalized to β-actin and presented as % CE + S. Representative blots are shown above
their respective bar graphs. *p < 0.0001 compared to control diet (Student's t-test), n = 8–12
in duplicate.
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Chronic ethanol exposure results in tolerance to increased phosphorylation of adrenal StAR
protein. Adrenal fractions were immunoprecipitated with phospho-PKA substrate antibody,
separated by SDS–PAGE and probed with StAR. A representative blot is shown above the
bar graph. For acute ethanol (E), results are reported as fold increase of phospho-StAR (P-
StAR) compared to saline (S). For chronic ethanol (CE) exposure, results are reported as
fold increase of phospho-StAR compared to control diet (CD). The fold increase of total
StAR (Tot-StAR) protein for both acute and chronic ethanol was also measured and
compared to its respective control. *p < 0.01 compared to total star for acute ethanol
(Student's t-test), n =4.
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Exogenous ACTH replacement restores serum and brain neuroactive steroid levels
following chronic ethanol exposure. Rats exposed to chronic dietary ethanol were
challenged with saline or ethanol (CE + S and CE + E, respectively). ACTH (2 μg, i.p.) was
administered along with the saline or ethanol challenge (CE + S + A and CE + E + A,
respectively). Tissues were collected 60 min after challenge and serum (a) ACTH and (b)
progesterone, as well as (c) cerebral cortical 3α,5α-THP were measured. *p < 0.001
compared to CE + S, #p < 0.05 compared to CE + S + A and CE + E, and @p < 0.05
compared to CE + S (ANOVA followed by Newman–Keuls test), n = 8–9 in duplicate.
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Phosphorylation of adrenal StAR protein is increased by ethanol and ACTH following
chronic dietary ethanol exposure. Adrenal fractions were immunoprecipitated with phospho-
PKA substrate antibody, separated by SDS–PAGE and probed with StAR antibody. A
representative blot is shown above the bar graph (P-StAR, phospho-StAR; Tot-StAR, total
StAR). Results are reported as the fold increase of phospho-StAR for each group compared
to the chronic ethanol and saline (CE + S) group. Total StAR was also measured and
reported as the fold increase for each group compared to the fold increase of total StAR for
the CE + S group. Chronic ethanol + ethanol (CE + E), chronic ethanol + saline + ACTH
(CE + S + A) and chronic ethanol + ethanol + ACTH (CE + E + A), n =6.
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